Opening book details…
About this book
Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of Enterobacterales from outpatient centers and nursing homes across the United States (2022–2024) by Aliaa Fouad & April M. Bobenchik & Robin Chamberland & Andrew E. Clark & Holly K. Huse & Isabella W. Martin & A. Brian Mochon & Erik Munson & Maroun M. Sfeir & Monica Srodon & Kimberly Taylor & Yungchou Wang & Lars F. Westblade & David P. Nicolau &... is a book available to read on EtoBox.
- Author
- Aliaa Fouad & April M. Bobenchik & Robin Chamberland & Andrew E. Clark & Holly K. Huse & Isabella W. Martin & A. Brian Mochon & Erik Munson & Maroun M. Sfeir & Monica Srodon & Kimberly Taylor & Yungchou Wang & Lars F. Westblade & David P. Nicolau &...
- Publisher
- American Society for Microbiology
- Published
- 2025
- Language
- EN
More by Aliaa Fouad & April M. Bobenchik & Robin Chamberland & Andrew E. Clark & Holly K. Huse & Isabella W. Martin & A. Brian Mochon & Erik Munson & Maroun M. Sfeir & Monica Srodon & Kimberly Taylor & Yungchou Wang & Lars F. Westblade & David P. Nicolau &...
Similar books
- In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program — James A. Karlowsky & Meredith A. Hackel & Gregory G. Stone & Daniel F. Sahm (2023)
- Ceftazidime-Decorated Gold Nanoparticles: a Promising Strategy against Clinical Ceftazidime-Avibactam-Resistant Enterobacteriaceae with Different Resistance Mechanisms — Zeyu Huang & Haifeng Liu & Xiaotuan Zhang & Miran Tang & Yuzhan Lin & Luozhu Feng & Jianzhong Ye & Tieli Zhou & Lijiang Chen (2023)
- Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against Pathogens Harboring OXA-48 and AmpC Alone or in Combination with Other β-Lactamases Collected from Phase 3 Clinical Trials and an International Surveillance Program — Lynn-Yao Lin & Dmitri Debabov & William Chang & Gregory Stone & Todd Riccobene (2022)
- In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020 — James A. Karlowsky & Sibylle H. Lob & C. Andrew DeRyke & David W. Hilbert & Michael T. Wong & Katherine Young & Fakhar Siddiqui & Mary R. Motyl & Daniel F. Sahm (2022)
- In Vitro Activity of Manogepix and Comparators Against Infrequently Encountered Yeast and Mold Isolates from the SENTRY Surveillance Program (2017–2022) — Michael Pfaller & Michael Huband & Paul A. Bien & Cecilia G. Carvalhaes & Abby Klauer & Mariana Castanheira (2024)
- Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018–2020 Global Surveillance Collection — James A. Karlowsky & Mark G. Wise & Meredith A. Hackel & Daniel C. Pevear & Greg Moeck & Daniel F. Sahm (2022)